May Measurement Month 2017-19: an analysis of blood pressure screening results from Paraguay.
Eur Heart J Suppl
; 24(Suppl F): F34-F37, 2022 Sep.
Article
em En
| MEDLINE
| ID: mdl-36225272
ABSTRACT
The aim of this study was to highlight the importance of measuring blood pressure (BP) and to identify and reduce the BPs of those people who require intervention to lower their BP according to current guidelines. A total of 7782 individuals aged ≥18 years were recruited during the 3 years of the May Measurement Month (MMM) campaign (2017 1196, 2018 2285, 2019 4301). Recruitment was through opportunistic sampling at a variety of screening sites distributed throughout the country. Each participant underwent a pre-specified questionnaire with questions on risk factors concluding with three BP measurements at 1â
min intervals and measurement of weight and height. Hypertension was defined as a systolic BP ≥140â
mmHg or diastolic BP ≥90â
mmHg or those receiving antihypertensive therapy. Of all 7782 participants, 3323 had hypertension (42.7%) of whom 61.8% were aware and 50.4% were not receiving antihypertensive medication. Of those treated (49.6%), 43.8% had controlled BP (<140/90â
mmHg). Among all hypertensive patients (with and without medication), 21.7% had controlled BP. In relation to previous surveys carried out in the country, awareness of hypertension increased two-fold, with no change in the proportion of hypertensive patients on treatment and the proportion of hypertensive patients with controlled BP which remained low.
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Qualitative_research
/
Screening_studies
País/Região como assunto:
America do sul
/
Paraguay
Idioma:
En
Revista:
Eur Heart J Suppl
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Paraguai